Keywords
antibiotics
community acquired pneumonia
children
How to Cite
Abstract
Action of antibiotics to the microorganisms in their biofilm forms was detected. Strains of Staphylococcus aureus, Streptococcus pneumoniae, Klebsiella pneumoniae, Pseudomonas aeruginosa were used in the research. Microorganisms were isoloated from children with community-acquired pneumonia. Ability of microorganisms to form biofilms was detected in 96-well plates. For detection action of antibacterial drugs to the biofilm forms of isolated microorganisms Ceftriaxon, Amikacin, Clarithromycin and Levofloxacin were chosen. Serial dilution method was used to determine susceptibility of microorganisms to the action of antibacterial drugs. All strains, which were isolated from patients with community acquired pneumonia, were able to form biofilms. Comparing optical density (OD) of S. aureus, S. pneumoniae and P. aeruginosa after action of antibiotics to the primary biofilms and OD of primary biofilms without action of antibacterial drugs revealed that in specific dilutions depth of primary biofilms with antibiotic action was thinner than depth of primary biofilms without action of antibacterial drugs. Comparing OD of S. aureus, S. pneumoniae and P. aeruginosa after action of antibiotics to the secondary biofilms and OD of secondary biofilms without action of antibacterial drugs revealed that in certain dilutions depth of secondary biofilms with antibiotic action was thicker than depth of secondary biofilms without action of antibacterial drugs.
Keywords: biofilms, antibiotics, community acquired pneumonia, children.
References
Grousd, J.A., Rich, Н.Е., & Alcorn, J.F. (2019). Host-pathogen interactions in Gram-Positive bacterial pneumonia. Clinical Microbiology Reviews, 32(3), e00107-18. DOI: 10.1128/CMR.00107-18. PMID: 31142498.
Fux, C.A., Costerton, J.W., Stewart, P.S., & Stoodley, P. (2005). Survival strategies of infectious biofilms. Trends in Microbiology, 13(1), 34-40. DOI: 10.1016/j.tim.2004.11.010. PMID: 15639630.
Boisvert, A.A., Cheng, M.P, Sheppard, D.C., & Nguyen, D. (2016). Microbial biofilms in pulmonary and critical care diseases. Annals of the American Thoracic Society, 13(9), 1615-1623. DOI: 10.1513/AnnalsATS.201603-194FR. PMID: 2734-8071.
Van Acker, H., Van Dijck, P, & Coenye, T. (2014). Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends in Microbiology, 22(6), 326-333. DOI: 10.1016/j.tim.2014.02.001. PMID: 24598086.
De la Fuente-Nunez, C., Reffuveille, F., Fernandez, L., & Hancock, R.E.W. (2013). Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Current Opinion in Microbiology, 16(5), 580-589. DOI: 10.1016/j.mib.2013.06.013. PMID: 23880136.
Taff, H.T., Mitchell, K.F., Edward, J.A., & Andes, D.R. (2013). Mechanisms of Candida biofilm drug resistance. Future Microbiology, 8(10), 1325-1337, DOI: 10.2217/fmb.l3.101. PMID: 24059922. PMCID: PMC3859465.
Colvin, K.M., Gordon, V.D., Murakami, K., Borlee, B.R., Wozniak, D.J., Wong, G.C.L., & Parsek, M.R. (2011). The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathogens., 7(1), el001264. DOI: 10.1371/joumal.ppat.1001264. PMID: 21298031.
Chiang, W.C., Nilsson, M., Jensen, P.O., Hoiby, N., Nielsen, T.E., Givskov, M., & Tolker-Nielsen, T. (2013). Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrobial Agents and Chemotherapy, 57(5), 2352-2361, DOI: 10.1128/AAC.00001-13. PMID: 24059922.
Maurice, N.M., Bedi, B., & Sadikot, R.T. (2018). Pseudomonas aeruginosa biofilms: host response and clinical implications in lung infections. American Journal of Respiratory Cell and Molecular Biology, 58(4), 428M39. DOI: 10.1165/rcmb.2017-0321TR. PMID: 29372812.
Romanova, Yu.M., Alekseieva, N.V., Smirnova, T.A., Andreiev, A.L., Didenko, L.V., & Gintsburg, A.L. (2006). Sposobnost к formirovaniiu bioplenok v iskusstvennykh sistemakh u razlichnykh shtammov Salmonella typhimurium [Biofilm formation by different strains of Salmonella typhimurium in artificial systems]. Zhurnal Microbiolohii, Epidemiolohii i Immunobiolohii - Journal of Microbiology, Epidemiology and Immunobiology, (4), 38-42 [in Russian].
Man, S.C., Sas, V., Schnell, C., Florea, C., Tutu, A., Szilagyi, A., et al. (2018). Antibiotic treatment in childhood community-acquired pneumonia - clinical practice versus guidelines : results from two university hospitals. Clujul Medical, 91(1), 53-57. DOI: 10.15386/cjmed-808 PMID: 29440952.
Alzomor, O., Alhajjar, S., Aljobair, F., Alenizi, A., Alodyani, A., Alzahrani, M. et al. (2017). Management of community-acquired pneumonia in infants and children: Clinical practice guidelines endorsed by the Saudi Pediatric Infectious Diseases Society. International Journal of Pediatrics and Adolescent Medicine, 4(4), 153-158. DOI: 10.1016/j.ijpam.2017.12.002. PMID: 30805522.
Bradley, J.S., Byington, C.L., Shah, S.S., Alverson, B., Carter, E.R., Harrison, C. et al. (2011). Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clinical Infectious Diseases, 53(7), e25-e76. DOI: 10.1093/cid/cir531. PMID: 21880587.
Nakaz MOZ Ukrainy vid 05.04.07 No.167. Pro zatverdzhennia metodychnykh vkazivok "Vyznachennia chutlyvosti mikroorhanizmiv do antybakterialnykh preparativ" [Order of the Ministry of Health of Ukraine dated 05 Apr 2007 No.167. On approval of methodical recommendations "Detection sensibility of microorganisms to antibacterial drugs"]. Retrieved from https://zakon.rada.gov.ua/rada/show/v0167282-07 [in Ukrainian].